"Designing Growth Strategies is in our DNA"

Tuberculosis (TB) Diagnostics Market Size, Share & Industry Analysis, By Type (Culture-based Diagnostics, Sputum Smear Microscopy, Rapid Molecular Diagnostics, and Others), By End-user (Diagnostics Laboratories and Hospitals), and Regional Forecast, 2024-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI102009

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Key Industry Developments
    2. Incidence of Tuberculosis, By Key Countries
    3. Impact of COVID-19 on the Market
  5. Global Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Culture-based Diagnostics
      2. Sputum Smear Microscopy
      3. Rapid Molecular Diagnostics
      4. Others
    2. Market Analysis, Insights and Forecast – By End-user
      1. Diagnostic Laboratories 
      2. Hospitals
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Culture-based Diagnostics
      2. Sputum Smear Microscopy
      3. Rapid Molecular Diagnostics
      4. Others
    2. Market Analysis, Insights and Forecast – By End-user
      1. Diagnostic Laboratories 
      2. Hospitals
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Culture-based Diagnostics
      2. Sputum Smear Microscopy
      3. Rapid Molecular Diagnostics
      4. Others
    2. Market Analysis, Insights and Forecast – By End-user
      1. Diagnostic Laboratories 
      2. Hospitals
    3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Russia
      6. Nordic
      7. Rest of Europe
  8. Asia Pacific Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Culture-based Diagnostics
      2. Sputum Smear Microscopy
      3. Rapid Molecular Diagnostics
      4. Others
    2. Market Analysis, Insights and Forecast – By End-user
      1. Diagnostic Laboratories 
      2. Hospitals
    3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. South Korea
      6. Southeast Asia
      7. Rest of Asia Pacific
  9. Latin America Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Culture-based Diagnostics
      2. Sputum Smear Microscopy
      3. Rapid Molecular Diagnostics
      4. Others
    2. Market Analysis, Insights and Forecast – By End-user
      1. Diagnostic Laboratories 
      2. Hospitals
    3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Culture-based Diagnostics
      2. Sputum Smear Microscopy
      3. Rapid Molecular Diagnostics
      4. Others
    2. Market Analysis, Insights and Forecast – By End-user
      1. Diagnostic Laboratories 
      2. Hospitals
    3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. bioMérieux SA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. QIAGEN
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. BD
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Cepheid (Danaher)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Abbott Laboratories
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Hologic, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Hain Lifescience GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Oxford Immunotec USA, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Tuberculosis (TB) Diagnostics Market Revenue Breakdown (USD Billion, %) by Region, 2023 & 2032

Figure 2: Global Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2023 & 2032

Figure 3: Global Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2023 & 2032

Figure 4: Global Tuberculosis (TB) Diagnostics Market Value (USD Billion), by Region, 2023 & 2032

Figure 5: North America Tuberculosis (TB) Diagnostics Market Value (USD Billion), by Type, 2023 & 2032

Figure 6: North America Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2023

Figure 7: North America Tuberculosis (TB) Diagnostics Market Value (USD Billion), by End-user, 2023 & 2032

Figure 8: North America Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2023

Figure 9: North America Tuberculosis (TB) Diagnostics Market Value (USD Billion), By Country, 2023 & 2032

Figure 10: North America Tuberculosis (TB) Diagnostics Market Value Share (%), By Country, 2023

Figure 11: Europe Tuberculosis (TB) Diagnostics Market Value (USD Billion), by Type, 2023 & 2032

Figure 12: Europe Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2023                                                      

Figure 13: Europe Tuberculosis (TB) Diagnostics Market Value (USD Billion), by End-user, 2023 & 2032

Figure 14: Europe Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2023

Figure 15: Europe Tuberculosis (TB) Diagnostics Market Value (USD Billion), By Country/ Sub-region, 2023 & 2032

Figure 16: Europe Tuberculosis (TB) Diagnostics Market Value Share (%), By Country/ Sub-region, 2023

Figure 17: Asia Pacific Tuberculosis (TB) Diagnostics Market Value (USD Billion), by Type, 2023 & 2032

Figure 18: Asia Pacific Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2023

Figure 19: Asia Pacific Tuberculosis (TB) Diagnostics Market Value (USD Billion), by End-user, 2023 & 2032

Figure 20: Asia Pacific Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2023

Figure 21: Asia Pacific Tuberculosis (TB) Diagnostics Market Value (USD Billion), By Country/ Sub-region, 2023 & 2032

Figure 22: Asia Pacific Tuberculosis (TB) Diagnostics Market Value Share (%), By Country/ Sub-region, 2023

Figure 23: Latin America Tuberculosis (TB) Diagnostics Market Value (USD Billion), by Type, 2023 & 2032

Figure 24: Latin America Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2023

Figure 25: Latin America Tuberculosis (TB) Diagnostics Market Value (USD Billion), by End-user, 2023 & 2032

Figure 26: Latin America Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2023

Figure 27: Latin America Tuberculosis (TB) Diagnostics Market Value (USD Billion), By Country/ Sub-region, 2023 & 2032

Figure 28: Latin America Tuberculosis (TB) Diagnostics Market Value Share (%), By Country/ Sub-region, 2023

Figure 29: Middle East & Africa Tuberculosis (TB) Diagnostics Market Value (USD Billion), by Type, 2023 & 2032

Figure 30: Middle East & Africa Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2023

Figure 31: Middle East & Africa Tuberculosis (TB) Diagnostics Market Value (USD Billion), by End-user, 2023 & 2032

Figure 32: Middle East & Africa Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2023

Figure 33: Middle East & Africa Tuberculosis (TB) Diagnostics Market Value (USD Billion), By Country/ Sub-region, 2023 & 2032

Figure 34: Middle East & Africa Tuberculosis (TB) Diagnostics Market Value Share (%), By Country/ Sub-region, 2023

Figure 35: Global Tuberculosis (TB) Diagnostics Market Share (%), By Company, 2023

Table 1: Global Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Type, 2019-2032

Table 2: Global Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by End-user, 2019-2032

Table 3: Global Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Region, 2019-2032

Table 4: North America Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Type, 2019-2032

Table 5: North America Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by End-user, 2019-2032

Table 6: North America Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, By Country, 2019-2032

Table 7: Europe Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Type, 2019-2032

Table 8: Europe Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by End-user, 2019-2032

Table 9: Europe Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

Table 10: Asia Pacific Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Type, 2019-2032

Table 11: Asia Pacific Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by End-user, 2019-2032

Table 12: Asia Pacific Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

Table 13: Latin America Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Type, 2019-2032

Table 14: Latin America Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by End-user, 2019-2032

Table 15: Latin America Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Middle East & Africa Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Type, 2019-2032

Table 17: Middle East & Africa Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by End-user, 2019-2032

Table 18: Middle East & Africa Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

  • 2019-2032
  • 2023
  • 2019-2022
  • 121
Consulting Services
    How will you benefit from our consulting services ?